Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Baird Downgrades Syneos Health to Neutral, Announces $43 Price Target

Author: Benzinga Newsdesk | May 11, 2023 05:54am
Baird analyst Eric Coldwell downgrades Syneos Health (NASDAQ:SYNH) from Outperform to Neutral and announces $43 price target.

Posted In: SYNH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist